Why the study?
The mechanisms by which regenerating cells adapt to injury-induced stress conditions and activate regenerative programs remain to be defined.
Absolute Event Rate: 40% vs 52%
p-value: p=0.0183
Nrf1 mediates an adaptive stress response involving proteasome activation and redox balance that is required for neonatal heart regeneration and protects the adult heart from ischemic and cardiotoxic injury.
Following injury, cells in regenerative tissues have the ability to regrow. The mechanisms whereby regenerating cells adapt to injury-induced stress conditions and activate the regenerative program remain to be defined. Here, using the mammalian neonatal heart regeneration model, we show that Nrf1, a stress-responsive transcription factor encoded by the Nuclear Factor Erythroid 2 Like 1 (Nfe2l1) gene, is activated in regenerating cardiomyocytes. Genetic deletion of Nrf1 prevented regenerating cardiomyocytes from activating a transcriptional program required for heart regeneration. Conversely, Nrf1 overexpression protected the adult mouse heart from ischemia/reperfusion (I/R) injury. Nrf1 also protected human induced pluripotent stem cell-derived cardiomyocytes from doxorubicin-induced cardiotoxicity and other cardiotoxins. The protective function of Nrf1 is mediated by a dual stress response mechanism involving activation of the proteasome and redox balance. Our findings reveal that the adaptive stress response mechanism mediated by Nrf1 is required for neonatal heart regeneration and confers cardioprotection in the adult heart.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2021) studied Myocardial infarction and cardiotoxicity. Nrf1 overexpression vs. Control vector (AAV9-TdTomato or LacZ) was evaluated on Infarct area after ischemia/reperfusion injury (p=0.0183).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: